{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Approves Lilly’s Oral GLP-1 Therapy for Obesity",
    "url": "https://www.lexblog.com/2026/04/30/fda-approves-lillys-oral-glp-1-therapy-for-obesity/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-E41P2F8M",
        "url": "https://www.lexblog.com/lib/E41P2F8M/"
    },
    "datePublished": "2026-04-30T16:59:17-04:00",
    "dateModified": "2026-05-01T15:59:29-04:00",
    "author": {
        "@type": "Person",
        "name": "Atara Kahn"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rivkin Radler"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Rivkin Rounds",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.rivkinrounds.com/?p=4567",
    "sourceStability": "may-move"
}